A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancer
- 1 November 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (16) , 2751-2756
- https://doi.org/10.1016/j.ejca.2006.08.014
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Overexpression of Cyclooxygenase-2 Is Associated with Breast Carcinoma and Its Poor Prognostic FactorsLaboratory Investigation, 2003
- Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast CancerJournal of Biological Chemistry, 2002
- Aromatase and COX-2 expression in human breast cancersThe Journal of Steroid Biochemistry and Molecular Biology, 2001
- Host cyclooxygenase-2 modulates carcinoma growthJournal of Clinical Investigation, 2000
- Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimensPublished by Elsevier ,1999
- Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancerMedical Hypotheses, 1999
- Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.Journal of Clinical Investigation, 1997
- Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) geneEndocrinology, 1996
- Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)Cell, 1996
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995